Harding Loevner LP’s Thermo Fisher Scientific Inc Position
Does Harding Loevner LP own Thermo Fisher Scientific Inc (TMO)? Yes — 139.8K shares worth $69M (+0.71% of its 13F portfolio) as of Q1 2026, down from 145.0K shares the prior filed quarter.
Position Value
$69M
Q1 2026
Shares
139.8K
% of Portfolio
+0.71%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 139.8K | $69M | +0.71% |
| Q4 2025 | 145.0K | $84M | +0.74% |
| Q3 2025 | 168.6K | $82M | +0.60% |
| Q2 2025 | 229.5K | $93M | +0.63% |
| Q1 2025 | 416.6K | $207M | +1.59% |
| Q4 2024 | 474.9K | $247M | +1.67% |
| Q3 2024 | 568.5K | $352M | +2.03% |
| Q2 2024 | 565.8K | $313M | +1.73% |
| Q1 2024 | 585.2K | $340M | +2.10% |
| Q4 2023 | 628.1K | $334M | +1.87% |
| Q3 2023 | 639.7K | $324M | +2.14% |
| Q2 2023 | 452.8K | $236M | +1.38% |
| Q1 2023 | 538.2K | $310M | +1.77% |
| Q4 2022 | 530.8K | $292M | +1.68% |
| Q3 2022 | 472.2K | $239M | +1.57% |
| Q2 2022 | 500.0K | $272M | +1.68% |
| Q1 2022 | 514.0K | $267M | +1.47% |
| Q4 2021 | 653.3K | $436M | +1.67% |
| Q3 2021 | 666.7K | $381M | +1.52% |
| Q2 2021 | 669.0K | $337M | +1.27% |
| Q1 2021 | 585.8K | $267M | +1.05% |
| Q4 2020 | 633.6K | $295M | +1.22% |
| Q3 2020 | 622.6K | $275M | +0.99% |
| Q2 2020 | 595.8K | $216M | +1.03% |
| Q1 2020 | 60 | $17,000 | 0.00% |
| Q4 2019 | 60 | $19,000 | 0.00% |
| Q3 2019 | 60 | $17,000 | 0.00% |
| Q2 2019 | 60 | $18,000 | 0.00% |
| Q1 2019 | 60 | $16,000 | 0.00% |
| Q4 2018 | 60 | $13,000 | 0.00% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Harding Loevner LP’s full portfolio or all institutional holders of TMO.